Clinical Trial

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to better understand the immune response to basal cell carcinoma (BCC) treated with Photodynamic Therapy (PDT) in order to develop new methods of treating BCC. Previous research suggests that PDT alters the immune response, possibly in a way that could promote better tumor clearance when combined with other treatments. Overall, participation in this study will help the study team better understand the anti-tumor immune response when BCC is treated with PDT.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-08-19; most recent amendment 2026-05-28.
Status change: Recruiting → Active, Not Recruiting 2026-05-28
Status change: Not Yet Recruiting → Recruiting 2021-12-02
Trial Details
NCT Number NCT05020912
Lead Sponsor Case Comprehensive Cancer Center
Conditions Basal Cell Carcinoma
Enrollment 18 participants
Start Date 2021-12-13
Primary Completion 2027-09 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-01